Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.85B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$653M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$629M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$591M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.17B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$981M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$416M |
| 4 |
Amazon
AMZN
|
+$402M |
| 5 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.9% |
| 2 | Healthcare | 5.31% |
| 3 | Financials | 5.25% |
| 4 | Communication Services | 4.61% |
| 5 | Consumer Discretionary | 4.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
PUT
Wheaton Precious Metals
WPM
$59.9B
| $812K | ﹤0.01% |
41,600
+30,400
| +271% | +$518K |
|
|
BPFH
3277
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $808K | ﹤0.01% |
76,412
-29,316
| -28% | -$369K |
|
3278
HUTCHMED
HCM
$2.11B
| $807K | ﹤0.01% |
+34,954
| New | +$1.09M |
|
3279
LifeVantage
LFVN
$81.9M
| $807K | ﹤0.01% |
61,200
+60,168
| +5,830% | +$720K |
|
3280
Tenaris
TS
$26.6B
| $807K | ﹤0.01% |
37,842
-75,649
| -67% | -$2.1M |
|
3281
CALL
Xylem
XYL
$28.1B
| $807K | ﹤0.01% |
12,100
+3,300
| +38% | +$228K |
|
|
BNFT
3282
DELISTED
Benefitfocus, Inc.
BNFT
| $807K | ﹤0.01% |
17,650
-12,024
| -41% | -$502K |
|
|
ACIA
3283
DELISTED
Acacia Communications Inc
ACIA
| $806K | ﹤0.01% |
21,227
-13,066
| -38% | -$528K |
|
|
PMT
3284
PennyMac Mortgage Investment
PMT
$828M
| $805K | ﹤0.01% |
43,266
-203,554
| -82% | -$4.06M |
|
3285
Talphera
TLPH
$62.8M
| $805K | ﹤0.01% |
+17,442
| New | +$1.17M |
|
|
FLOW
3286
DELISTED
SPX FLOW, Inc.
FLOW
| $805K | ﹤0.01% |
26,448
-32,145
| -55% | -$1.21M |
|
3287
Enova International
ENVA
$6.52B
| $804K | ﹤0.01% |
41,311
-25,429
| -38% | -$579K |
|
|
CDK
3288
PUT
DELISTED
CDK Global, Inc.
CDK
| $804K | ﹤0.01% |
16,800
+13,300
| +380% | +$702K |
|
3289
CALL
Stratasys
SSYS
$779M
| $801K | ﹤0.01% |
44,500
+24,100
| +118% | +$504K |
|
3290
Apyx Medical
APYX
$128M
| $800K | ﹤0.01% |
+123,417
| New | +$748K |
|
3291
CALL
Fomento Económico Mexicano
FMX
$39.7B
| $800K | ﹤0.01% |
9,300
-7,500
| -45% | -$666K |
|
|
JKS
3292
JinkoSolar
JKS
$853M
| $799K | ﹤0.01% |
80,745
+72,693
| +903% | +$718K |
|
|
MNK
3293
CALL
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $799K | ﹤0.01% |
50,600
+9,700
| +24% | +$242K |
|
|
NBL
3294
CALL
DELISTED
Noble Energy, Inc.
NBL
| $799K | ﹤0.01% |
42,600
-223,200
| -84% | -$5.71M |
|
3295
Greif
GEF
$5.03B
| $798K | ﹤0.01% |
21,502
-3,448
| -14% | -$161K |
|
3296
iShares MSCI Indonesia ETF
EIDO
$484M
| $797K | ﹤0.01% |
+32,115
| New | +$747K |
|
|
TUP
3297
DELISTED
Tupperware Brands Corporation
TUP
| $796K | ﹤0.01% |
25,259
-52,770
| -68% | -$1.84M |
|
3298
Enanta Pharmaceuticals
ENTA
$391M
| $795K | ﹤0.01% |
11,234
-17,299
| -61% | -$1.33M |
|
|
CHU
3299
DELISTED
China Unicom (HONG KONG) Limited
CHU
| $795K | ﹤0.01% |
74,576
+38,400
| +106% | +$427K |
|
|
MDCO
3300
CALL
DELISTED
Medicines Co
MDCO
| $794K | ﹤0.01% |
41,500
+39,500
| +1,975% | +$919K |
|
Similar funds
Barclays's Q4 2018 Portfolio in Review
As of Q4 2018, Barclays held 7,834 positions worth $129B, down 10% from $144B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Barclays deployed $5.69B of net new capital in Q4 2018, opening 489 new positions and adding to 2,471 existing holdings. Its largest new stake was Linde: 7,232,686 shares worth $1.13B.
By sector, the portfolio is most concentrated in Technology at 6.9% of assets, down from 8.2% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Fortive, an estimated $1.17B trimmed.
- Barclays's largest Q4 2018 buy was Linde: 7,232,686 shares worth $1.13B.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $1.85B increase.
- Barclays's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.17B.
- Barclays fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $184M.
- Barclays's ten largest holdings make up 32% of its $129B portfolio in Q4 2018.
- Barclays opened 489 new positions and closed 777 in Q4 2018.
- Barclays's portfolio value fell 10% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q4 2018, filed 14 Feb 2019.